| Primary information |
|---|
| sequence ID | Seq_3286 |
| Peptide sequence | GVANALAHK |
| CancerPDF_ID | CancerPDF_ID11535, CancerPDF_ID13920, CancerPDF_ID13921, |
| PMID | 26992070,20974924,20974924 |
| Protein Name | Hemoglobin subunit beta,Hemoglobin subunit delta,Hemoglobin subunit delta |
| UniprotKB Entry Name | HBB_HUMAN,HBD_HUMAN,HBD_HUMAN |
| Fluid | Serum,Plasma,Plasma |
| M/Z | 879.49265,880.501,880.501 |
| Charge | NA,2,2 |
| Mass (in Da) | 880.5031604,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,LC-MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | FDR 1 %,NA,NA |
| CancerPDF_ID | CancerPDF_ID11535, CancerPDF_ID13920, CancerPDF_ID13921, |
| p-Value | NA,NA,NA |
| Software | SEQUEST and Maxquant,MASCOT and SEQUEST,MASCOT and SEQUEST |
| Length | 7,NA,NA |
| Cancer Type | Melanoma,"Multiple myeloma patients, Acute myeloid leukemia","Multiple myeloma patients, Acute myeloid leukemia" |
| Database | SwissProt Database,Uniprot database,Uniprot database |
| Modification | NA,NA,NA |
| Number of Patients | 8 cancer samples and 4 healthy samples,NA,NA |
| Regulation | "Present in 3 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples.",NA,NA |
| Validation | na,NA,NA |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |